H4B Boston

Arrow down icon
MM+M 2023 Rare Disease Agency of the Year Award Logo and text
H4B Boston featured artwork on wall inside office

H4B Boston is the premier commercialization and marketing partner for orphan drugs and rare disease markets.

In a setting where natural history, diagnosis, care pathways, awareness, and access are almost always underdeveloped, it takes rigorous strategic thinking, deep medical knowledge, and extensive rare disease commercial experience to navigate the right path forward.

Our strategic advisory team brings incredible depth and breadth of experience navigating pivotal moments across a rare disease product or portfolio’s life cycle —

from early commercial analysis and insight development, advocacy and community engagement strategy, scientific platform, and brand development through LOE. Whether for disease state education or promotional advertising, our creative team transforms the complex science of rare diseases and life-changing therapies into powerful campaigns and brand experiences for HCPs, patients, and caregivers.

Find out how our strategic advisory team and creative agency capabilities shape brands that positively alter the health trajectory for people impacted by rare diseases.

Contact us today
What we’re up to lately

World Orphan Drug Congress (WOD), USA

May 23-25, 2023

Gaylord National Resort & Convention Center, Washington, DC


We are proud to be a Gold sponsor of the 2023 WOD Congress, the world’s most important orphan drug and rare disease event!

Our managing director, Kristin Marvin-Keller, will be monitoring a panel, “Commercializing cell and gene therapies for rare diseases.” Follow our social channels to keep up-to-date on the conference.

2023 BIO International Convention

June 5-8, 2023

Boston Convention and Exhibition Center, Boston, MA


We hope to see many of you there!

RARE Patient Advocacy Summit

September 19-21, 2023

Sheraton San Diego Hotel & Marina, San Diego, CA


We are a member of Global Genes and its RARE Corporate Alliance, a partnership of rare disease industry stakeholders committed to forging and supporting collaboration between industry and patient communities. As part of our commitment to patients with rare disease, we will be attending the Alliance’s patient advocacy summit this fall.

“Empathy is creativity in motion.”

- Kam Redlawsk, artist

We are proud to showcase the work of Kam Redlawsk on our walls at H4B Boston. Kam illustrates moments from her life living with a rare disease known as GNE myopathy since the age of 20. Kam’s moving portrayals serve to connect us personally to the struggles, triumphs, and journeys of the rare disease community. Every day, Kam’s art fuels our passion for human purpose and the promise of high science to give patients the answers they deserve.